Join Ed Vital, from the University of Leeds, and Chair of the Lupus Forum, along with Professor Vibeke Strand, Adjunct Clinical Professor of Immunology and Rheumatology at Stanford University School of Medicine in Palo Alto, California as they discuss the impact of the recent EULAR 2023 recommendations for SLE including LN, emerging therapies for CLE and real-world data for anifrolumab.